Abstract
The management of community-acquired pneumonia remains mainly driven by empiric antibiotic therapy because existing microbiological techniques are relatively insensitive and rarely deliver an answer within a useful time frame. Advances in the molecular detection of Streptococcus pneumoniae in whole blood have been published that suggest that a new era of diagnostics may be ready for routine clinical practice. As well as improved sensitivity over existing culture techniques and a very high specificity, the new assays quantitate the amount of bacteremia which appears to be an extremely useful prognostic marker. Here we review the recent studies and their implications in the setting of pneumococcoal pneumonia.
Keywords: Pneumococcus, PCR, quantitative, bacterial load, Molecular Diagnosis, community-acquired pneumonia, antibiotic therapy, blood, culture techniques, high specificity, alpha-hemolytic, respiratory tract, real-time PCR, DNA
Current Respiratory Medicine Reviews
Title: New Developments in Molecular Diagnosis of Bacteremic Pneumococcal Pneumonia
Volume: 7 Issue: 4
Author(s): Cordelia Kee, Ian Kay and Grant W. Waterer
Affiliation:
Keywords: Pneumococcus, PCR, quantitative, bacterial load, Molecular Diagnosis, community-acquired pneumonia, antibiotic therapy, blood, culture techniques, high specificity, alpha-hemolytic, respiratory tract, real-time PCR, DNA
Abstract: The management of community-acquired pneumonia remains mainly driven by empiric antibiotic therapy because existing microbiological techniques are relatively insensitive and rarely deliver an answer within a useful time frame. Advances in the molecular detection of Streptococcus pneumoniae in whole blood have been published that suggest that a new era of diagnostics may be ready for routine clinical practice. As well as improved sensitivity over existing culture techniques and a very high specificity, the new assays quantitate the amount of bacteremia which appears to be an extremely useful prognostic marker. Here we review the recent studies and their implications in the setting of pneumococcoal pneumonia.
Export Options
About this article
Cite this article as:
Kee Cordelia, Kay Ian and W. Waterer Grant, New Developments in Molecular Diagnosis of Bacteremic Pneumococcal Pneumonia, Current Respiratory Medicine Reviews 2011; 7(4) . https://dx.doi.org/10.2174/157339811798281269
DOI https://dx.doi.org/10.2174/157339811798281269 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Heat Shock Protein Inhibitors for the Treatment of Fungal Infections
Recent Patents on Anti-Infective Drug Discovery The Injured Cochlea as a Target for Inflammatory Processes, Initiation of Cell Death Pathways and Application of Related Otoprotective Strategies
Recent Patents on CNS Drug Discovery (Discontinued) Acid Sensing Ion Channels and Acid Nociception
Current Pharmaceutical Design The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Intranasal Fluorescent Nanocrystals for Longitudinal <i>In Vivo</i> Evaluation of Cerebral Microlesions
Pharmaceutical Nanotechnology Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit
Infectious Disorders - Drug Targets Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Dysfunctions of the Diffusional Membrane Pathways Mediated Hemichannels in Inherited and Acquired Human Diseases
Current Vascular Pharmacology Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine
Current Medicinal Chemistry The Role of Toll-Like Receptors and Type I Interferons in Host Responses to Bacteria
Current Immunology Reviews (Discontinued) Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies
Current Topics in Medicinal Chemistry Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas
Recent Patents on CNS Drug Discovery (Discontinued) 5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines
CNS & Neurological Disorders - Drug Targets Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier
Current Cancer Drug Targets Group A Streptococcal Infections in Children
Current Pediatric Reviews Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews Cognitive Functions under Anti-HER2 Targeted Therapy in Cancer Patients: A Scoping Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of New Hexahydroindazole Derivatives of Curcumin
Letters in Drug Design & Discovery Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS
Current Drug Metabolism